Lornicam Rapid 8 mg 10 tablets

Tradename

Lornicam Rapid

Lornicam Rapid

Compound:

Each tablet contains:

Lornoxicam 8 mg

Auxiliary components:

Lactose monohydrate, microcrystalline cellulose, crosspovidone, povidone K90, colloidal silicon dioxide, anhydrous sodium citrate, magnesium stearate.

Properties

NSAIDs, belongs to the class of oxycams. It has a pronounced anti-inflammatory and analgesic effect, and also has antipyretic and antiplatelet effects.

The mechanism of action is associated with the suppression of inflammatory factors; inhibition of prostaglandin synthesis due to inhibition of COX1 and COX2, which leads to disruption of the metabolism of arachidonic acid and inhibition of prostaglandin synthesis both in the focus of inflammation and in healthy tissues. Suppresses the exudative and proliferative phases of inflammation.

Indications

Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, articular syndrome with exacerbation of gout, bursitis, tendovaginitis.

Moderate and severe pain syndrome (including arthralgia, myalgia, neuralgia, lumbago, sciatica, migraine, toothache and headache, algomenorrhea, pain from injuries, burns). Feverish syndrome (with colds and infectious diseases).

Dosage and administration

Inside, 8 mg. With insufficient analgesic effect at a dose of 8 mg, another 8 mg can be taken again.

Maximum daily doses: when taken orally — 16 mg; with concomitant diseases of the gastrointestinal tract, impaired renal or hepatic function, elderly patients (over 65 years old), with a body weight of less than 50 kg, and also after extensive surgery — 12 mg in 3 doses.

Contraindications

Acute bleeding from the gastrointestinal tract, peptic ulcer of the stomach and duodenum in the acute phase, ulcerative colitis in the acute phase, bronchial asthma, severe chronic heart failure, hypovolemia, blood clotting disorders (including hemophilia, hemorrhagic diathesis, thrombocytopenia), severe hepatic and / or renal failure, glucose-6-phosphate dehydrogenase deficiency, cerebral hemorrhage (including suspicion), pregnancy, lactation, children and adolescents under 18 years of age, hypersensitivity to lornoxicam, acetylsalicylic acid or other NSAIDs.

Precautionary measures:

Use with caution in erosive and ulcerative lesions and bleeding from the gastrointestinal tract (in history), moderately severe renal failure, conditions after surgical interventions, in elderly patients (over 65 years), in patients weighing less than 50 kg.

Side effects

Acute bleeding from the gastrointestinal tract, peptic ulcer of the stomach and duodenum in the acute phase, ulcerative colitis in the acute phase, bronchial asthma, severe chronic heart failure, hypovolemia, blood clotting disorders (including hemophilia, hemorrhagic diathesis, thrombocytopenia), severe hepatic and / or renal failure, deficiency of glucose-6-phosphate dehydrogenase, cerebral hemorrhage (including suspicion), pregnancy, lactation.

Storage method:

Store at a temperature not exceeding 30 degrees.